$CTGO
Contango ORE, Inc. Stock $ctgo

$ctgo Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000143774923025785 Filed on September 13, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.770M	$2.510M	$9.090M
YoY Change	14.27%	7.2%	-12.06%
% of Gross Profit
Research & Development	$1.210M	$1.137M	$8.410M
YoY Change	-73.37%	-74.86%	-7.98%
% of Gross Profit
Depreciation & Amortization	$26.00K	$33.86K	$136.5K
YoY Change	-24.02%	6.51%	144.89%
% of Gross Profit
Operating Expenses	$4.000M	$3.681M	$17.29M
YoY Change	-39.97%	-46.62%	-11.48%
Operating Profit	-$9.615M
YoY Change
Interest Expense	-$9.150M	-$7.334M	-$23.06M
YoY Change	-2135.73%	2148.0%	-7086.88%
% of Operating Profit
Other Income/Expense, Net	-$9.144M	$606.5K	-$22.09M
YoY Change	10413.92%	1363.21%	453.19%
Pretax Income	-$13.15M	-$10.42M	-$39.74M
YoY Change	85.43%	44.03%	68.21%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$13.15M	-$10.42M	-$39.74M
YoY Change	85.42%	44.03%	69.06%
Net Earnings / Revenue
Basic Earnings Per Share	-$1.47	-$1.38	-$5.61
Diluted Earnings Per Share	-$1.47	-$1.38	-$5.61
COMMON SHARES
Basic Shares Outstanding	9.394M	7.620M	7.087M
Diluted Shares Outstanding	8.936M	7.547M	7.087M

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.51M	$11.65M	$11.65M
YoY Change	3.93%	-49.57%	-49.57%
Cash & Equivalents	$18.51M	$11.65M
Short-Term Investments
Other Short-Term Assets	$1.580M	$644.9K	$644.9K
YoY Change	135.48%	-5.76%	-5.76%
Inventory
Prepaid Expenses	$795.1K	$413.9K
Receivables
Other Receivables
Total Short-Term Assets	$20.08M	$12.29M	$12.29M
YoY Change	8.67%	-48.31%	-48.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.35M	$13.37M	$13.37M
YoY Change	-0.95%	-1.06%	-1.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.42M	$0.00	$0.00
YoY Change
Other Assets	$34.77M	$13.37M	$350.6K
YoY Change	157.96%	-1.06%
Total Long-Term Assets	$34.77M	$13.37M	$13.37M
YoY Change	157.96%	-1.06%	-1.06%
TOTAL ASSETS
Total Short-Term Assets	$20.08M	$12.29M	$12.29M
Total Long-Term Assets	$34.77M	$13.37M	$13.37M
Total Assets	$54.86M	$25.66M	$25.66M
YoY Change	71.63%	-31.19%	-31.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.129M	$220.8K	$220.8K
YoY Change	75.93%	-65.17%	-65.17%
Accrued Expenses	$871.7K	$2.078M	$2.078M
YoY Change	-21.06%	138.57%	138.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.000M	$0.00	$7.900M
YoY Change
Total Short-Term Liabilities	$5.001M	$2.299M	$2.299M
YoY Change	116.06%	52.75%	52.75%
LONG-TERM LIABILITIES
Long-Term Debt	$32.86M	$25.46M	$25.46M
YoY Change	70.35%	32.31%	32.31%
Other Long-Term Liabilities	$5.960M	$2.681M	$2.681M
YoY Change	81.81%	-18.16%	-18.16%
Total Long-Term Liabilities	$38.81M	$28.14M	$28.14M
YoY Change	72.01%	24.97%	24.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.001M	$2.299M	$2.299M
Total Long-Term Liabilities	$38.81M	$28.14M	$28.14M
Total Liabilities	$43.81M	$30.44M	$30.44M
YoY Change	76.11%	26.71%	26.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$111.4M	-$98.28M
YoY Change	69.79%	67.89%
Common Stock	$122.5M	$93.50M
YoY Change	63.65%	26.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.04M	-$4.773M	-$4.773M
YoY Change
Total Liabilities & Shareholders Equity	$54.86M	$25.66M	$25.66M
YoY Change	71.63%	-31.19%	-31.19%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$13.15M	-$10.42M	-$39.74M
YoY Change	85.42%	44.03%	69.06%
Depreciation, Depletion And Amortization	$26.00K	$33.86K	$136.5K
YoY Change	-24.02%	6.51%	144.89%
Cash From Operating Activities	-$3.552M	-$1.106M	-$14.68M
YoY Change	-32.41%	-76.45%	5.26%
INVESTING ACTIVITIES
Capital Expenditures	$6.995K	$0.00	$0.00
YoY Change			-100.0%
Acquisitions			$719.00
YoY Change			-99.99%
Other Investing Activities	-$27.03M	-$6.720M	-$21.12M
YoY Change			37.61%
Cash From Investing Activities	-$27.04M	-$6.720M	-$21.12M
YoY Change			37.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$37.45M	16.55M	$24.35M
YoY Change	-123173.78%	-16.42%	39.6%
NET CHANGE
Cash From Operating Activities	-$3.552M	-1.106M	-$14.68M
Cash From Investing Activities	-$27.04M	-6.720M	-$21.12M
Cash From Financing Activities	$37.45M	16.55M	$24.35M
Net Change In Cash	$6.861M	8.727M	-$11.45M
YoY Change	-229.81%	-42.24%	-3.75%
FREE CASH FLOW
Cash From Operating Activities	-$3.552M	-$1.106M	-$14.68M
Capital Expenditures	$6.995K	$0.00	$0.00
Free Cash Flow	-$3.559M	-$1.106M	-$14.68M
YoY Change	-32.27%	-76.45%	4.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7781690
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7781690
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6860420
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6769923
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	90497
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3993094	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	231000	usd
CY2020Q4	ctgo	Rights Agreement Number Of Preferred Stock Issuable Per Right RightsAgreementNumberOfPreferredStockIssuablePerRight	0.001
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-54136
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3431051
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3700 BUFFALO SPEEDWAY, SUITE 925
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77098
CY2023	dei	City Area Code CityAreaCode	713
CY2023	dei	Local Phone Number LocalPhoneNumber	877-1311
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	CTGO
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	91041747	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9393922
CY2023	dei	Auditor Name AuditorName	Moss Adams LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023	dei	Auditor Firm AuditorFirmId	659
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11646194	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23095101	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	231000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	231000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	413907	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	453353	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	12291101	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	23779454	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13371638	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13514531	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13371638	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13514531	usd
CY2023Q2	us-gaap	Assets Assets	25662739	usd
CY2022Q2	us-gaap	Assets Assets	37293985	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	220755	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	633856	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2077870	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	870981	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2298625	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1504837	usd
CY2023Q2	ctgo	Advance Royalty Reimbursement Noncurrent AdvanceRoyaltyReimbursementNoncurrent	1200000	usd
CY2022Q2	ctgo	Advance Royalty Reimbursement Noncurrent AdvanceRoyaltyReimbursementNoncurrent	1200000	usd
CY2023Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	239942	usd
CY2022Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	228082	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1240563	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1847063	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25457047	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19239960	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	28137552	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22515105	usd
CY2023Q2	us-gaap	Liabilities Liabilities	30436177	usd
CY2022Q2	us-gaap	Liabilities Liabilities	24019942	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	77817	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	68604	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	93424283	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74057859	usd
CY2023Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	-0	usd
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2318182	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-98275538	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58534238	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4773438	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13274043	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25662739	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37293985	usd
CY2023	ctgo	Claim Rental Expense ClaimRentalExpense	526279	usd
CY2022	ctgo	Claim Rental Expense ClaimRentalExpense	621298	usd
CY2023	us-gaap	Exploration Expense ExplorationExpense	7878863	usd
CY2022	us-gaap	Exploration Expense ExplorationExpense	8517938	usd
CY2023	us-gaap	Depreciation Nonproduction DepreciationNonproduction	136501	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	55740	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	11860	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	9156	usd
CY2023	ctgo	Impairment From Casualty Loss ImpairmentFromCasualtyLoss	7111	usd
CY2022	ctgo	Impairment From Casualty Loss ImpairmentFromCasualtyLoss	92777	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9091127	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10336378	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	17651741	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	19633287	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	29651	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1503	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1959666	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-330047	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-21120000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3706000	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	622155	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	41450	usd
CY2023	us-gaap	Insurance Recoveries InsuranceRecoveries	338301	usd
CY2022	us-gaap	Insurance Recoveries InsuranceRecoveries	0	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-22089559	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39741300	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23626381	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-119731	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-39741300	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23506650	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.61
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.49
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7087027
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6734444
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-39741300	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23506650	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2931288	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3993660	usd
CY2023	us-gaap	Depreciation Depreciation	136501	usd
CY2022	us-gaap	Depreciation Depreciation	55740	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	11860	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	9156	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	7111	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	115025	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	438877	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-606500	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1		usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	190358	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	34675	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-21120000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3706000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-39446	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-176914	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	793788	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1271899	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-0	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-198126	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14678571	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13945455	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	21120000	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3706000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43989	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	719	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11642586	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21120719	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15392575	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	126428	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	779622	usd
CY2023	ctgo	Payment Tax Withholding Sharebased Payment Arrangement Stock Vesting PaymentTaxWithholdingSharebasedPaymentArrangementStockVesting	-0	usd
CY2022	ctgo	Payment Tax Withholding Sharebased Payment Arrangement Stock Vesting PaymentTaxWithholdingSharebasedPaymentArrangementStockVesting	1538560	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7647500	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	19969967	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1620771	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	164682	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6886000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023	ctgo	Proceeds From Repurchase Of Capital Raises Net ProceedsFromRepurchaseOfCapitalRaisesNet	11564082	usd
CY2022	ctgo	Proceeds From Repurchase Of Capital Raises Net ProceedsFromRepurchaseOfCapitalRaisesNet	-43560	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24350383	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17443543	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11448907	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11894487	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23326101	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	35220588	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11877194	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23326101	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1324474	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	218546	usd
CY2023	ctgo	Asset Retirement Obligations Noncash Transaction AssetRetirementObligationsNoncashTransaction	0	usd
CY2022	ctgo	Asset Retirement Obligations Noncash Transaction AssetRetirementObligationsNoncashTransaction	218927	usd
CY2023	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	usd
CY2022	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	1847063	usd
CY2023	ctgo	Establishment Fee For Convertible Debt Paid With Stock Issuance EstablishmentFeeForConvertibleDebtPaidWithStockIssuance	0	usd
CY2022	ctgo	Establishment Fee For Convertible Debt Paid With Stock Issuance EstablishmentFeeForConvertibleDebtPaidWithStockIssuance	600000	usd
CY2023	ctgo	Fair Value Of Investing Activities Assumed FairValueOfInvestingActivitiesAssumed	0	usd
CY2022	ctgo	Fair Value Of Investing Activities Assumed FairValueOfInvestingActivitiesAssumed	2665990	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	34548775	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3993660	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	600000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	43560	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	779622	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23506650	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13274043	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2931288	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8924620	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	661109	usd
CY2023	ctgo	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	5858772	usd
CY2023	ctgo	Adjustments To Additional Paid In Capital Warrant Exercise AdjustmentsToAdditionalPaidInCapitalWarrantExercise	-382769	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2505284	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	438877	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	126428	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-39741300	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4773438	usd
CY2023	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">2.</em> Basis of Presentation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt; text-align: justify;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	92777	usd
	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	92777	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	141905	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-119731	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	231000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<i>Management Estimates</i>. The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Other items subject to estimates and assumptions include, but are <em style="font: inherit;">not</em> limited to, the carrying amounts of property and equipment, asset retirement obligations, valuation of contingent consideration, valuation allowances for deferred income tax assets, valuation of derivative instruments and valuation of certain performance-based restricted stock unit awards. Management evaluates estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic and commodity price environment.
CY2023	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	7111	usd
CY2023	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<i>Derivative Asset for Embedded Conversion Features.</i> The Company evaluates convertible notes to determine if those contracts or embedded components of those contracts qualify as derivatives to be accounted for separately. In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are evaluated and accounted for separately. The result of this accounting treatment is that the fair value of the embedded derivative is recorded as either an asset or a liability and marked-to-market each balance sheet date, with the change in fair value recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. The fair value of the embedded conversion features are estimated using several probability weighted binomial lattice models. Estimating fair values of embedded conversion features is classified within Level <em style="font: inherit;">3</em> of the fair value hierarchy and requires the development of significant and subjective estimates that <em style="font: inherit;"> may, </em>and are likely to, change over the duration of the instrument with related changes in internal and external market factors.
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	11860	usd
CY2022	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	9156	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	413907	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	453353	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-39741300	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-23506650	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7087027
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6734444
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7087027
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6734444
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.61
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.49
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.61
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.49
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	401000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7781690
CY2023Q2	ctgo	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Warrants Outstanding Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndWarrantsOutstandingNumber	501000
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	ctgo	Rights Agreement Exercise Price RightsAgreementExercisePrice	100.00
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	192241	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	55740	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	122136	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	115025	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13371638	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13514531	usd
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	100000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2900000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000000.0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	7.42	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-261636	usd
CY2019Q1	ctgo	Contingent Salary And Compensation Retention Agreement ContingentSalaryAndCompensationRetentionAgreement	1500000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8345673	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4961540	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3225218	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1544567	usd
CY2023	ctgo	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	0	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	-38	usd
CY2023	ctgo	Effective Income Tax Rate Reconciliation Permanent Differences Amount EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount	19916	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Permanent Differences Amount EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount	12937	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-527765	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	100666	usd
CY2023	ctgo	Effective Income Tax Rate Reconciliation Legal Fees Amount EffectiveIncomeTaxRateReconciliationLegalFeesAmount	24167	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Legal Fees Amount EffectiveIncomeTaxRateReconciliationLegalFeesAmount	131311	usd
CY2023	ctgo	Effective Income Tax Rate Reconciliation Convertible Debt Interest Amount EffectiveIncomeTaxRateReconciliationConvertibleDebtInterestAmount	368875	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation Convertible Debt Interest Amount EffectiveIncomeTaxRateReconciliationConvertibleDebtInterestAmount	66463	usd
CY2023	ctgo	Effective Income Tax Rate Reconciliation162m Limitation Amount EffectiveIncomeTaxRateReconciliation162mLimitationAmount	373763	usd
CY2022	ctgo	Effective Income Tax Rate Reconciliation162m Limitation Amount EffectiveIncomeTaxRateReconciliation162mLimitationAmount	84822	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11311935	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5990215	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-119731	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q2	ctgo	Deferred Tax Assets Capitalized Exploration DeferredTaxAssetsCapitalizedExploration	14203470	usd
CY2022Q2	ctgo	Deferred Tax Assets Capitalized Exploration DeferredTaxAssetsCapitalizedExploration	8278223	usd
CY2023Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	6728285	usd
CY2022Q2	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	3503066	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1106783	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1425498	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5027243	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2547058	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27065781	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15753845	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11300000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	25457047000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	19239960000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001437749-23-025785-index-headers.html	Edgar Link	pending
0001437749-23-025785-index.html	Edgar Link	pending
0001437749-23-025785.txt	Edgar Link	pending
0001437749-23-025785-xbrl.zip	Edgar Link	pending
a01.jpg	Edgar Link	pending
a02.jpg	Edgar Link	pending
a03.jpg	Edgar Link	pending
a04.jpg	Edgar Link	pending
a05.jpg	Edgar Link	pending
a06.jpg	Edgar Link	pending
a08.jpg	Edgar Link	pending
a09.jpg	Edgar Link	pending
a10.jpg	Edgar Link	pending
conta20230630_10k.htm	Edgar Link	pending
ctgo-20230630.xsd	Edgar Link	pending
ex_546704.htm	Edgar Link	pending
ex_546705.htm	Edgar Link	pending
ex_546706.htm	Edgar Link	pending
ex_546707.htm	Edgar Link	pending
ex_546708.htm	Edgar Link	pending
ctgo-20230630_cal.xml	Edgar Link	unprocessable
ctgo-20230630_pre.xml	Edgar Link	unprocessable
ctgo-20230630_def.xml	Edgar Link	unprocessable
ctgo-20230630_lab.xml	Edgar Link	unprocessable
conta20230630_10k_htm.xml	Edgar Link	completed
ex_546709.htm	Edgar Link	pending
ex_546710.htm	Edgar Link	pending
ex_546711.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
image02.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTGO
Contango ORE, Inc. Stock $ctgo

2023 Q3 Form 10-K Financial Statement

#000143774923025785 Filed on September 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTGO Contango ORE, Inc. Stock $ctgo

2023 Q3 Form 10-K Financial Statement

#000143774923025785 Filed on September 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTGO
Contango ORE, Inc. Stock $ctgo